Home » Topics » Disease categories and therapies » Urology

Urology
RSS

New clinical outcomes trial of Jardiance planned in chronic kidney disease

June 13, 2017

No Comments

Kissei gains exclusive rights to develop and commercialize avacopan in Japan

June 9, 2017

No Comments

Vitros NephroCheck test becomes available in Europe

June 9, 2017

No Comments

Roivant Sciences launches new company

June 8, 2017

No Comments

Pfizer begins first-in-human study of PF-06730512

June 7, 2017

No Comments

Palladio Biosciences acquires rights to lixivaptan

May 24, 2017

No Comments

EMA grants orphan drug designation to avacopan for C3 glomerulopathy

May 24, 2017

No Comments

Otsuka reports topline results from phase III study of tolvaptan in ADPKD

May 23, 2017

No Comments

Aurinia initiates phase III study of voclosporin for lupus nephritis

May 18, 2017

No Comments

Omeros provides update on phase II study of OMS-721

May 18, 2017

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Urology
RSS

New clinical outcomes trial of Jardiance planned in chronic kidney disease

Kissei gains exclusive rights to develop and commercialize avacopan in Japan

Vitros NephroCheck test becomes available in Europe

Roivant Sciences launches new company

Pfizer begins first-in-human study of PF-06730512

Palladio Biosciences acquires rights to lixivaptan

EMA grants orphan drug designation to avacopan for C3 glomerulopathy

Otsuka reports topline results from phase III study of tolvaptan in ADPKD

Aurinia initiates phase III study of voclosporin for lupus nephritis

Omeros provides update on phase II study of OMS-721

Today's news in brief

Today's news in brief

Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal

Proteomics study explores how protein changes influence disease

Abbvie and Simcere enter a $1B T-cell engager deal

Urology RSS

Urology
RSS